Roselabs Finance Intrinsic Value
Roselabs Finance (ROSELABS) median intrinsic value is ₹6.24 from 1 valuation models (range ₹6–₹6), vs current price ₹20.80 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Check ROSELABS market cap trends to track the company's total market size over time.
ROSELABS Valuation Methods Summary — DCF, Graham Number & P/E
Roselabs Finance intrinsic value across 1 models vs current price ₹20.80 — upside/downside and value range per method. See ROSELABS book value to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹6.24 | ₹5.62 - ₹6.86 | -70.0% | Revenue/Share: ₹1.00, P/S: 1.0x |
ROSELABS Intrinsic Value vs Market Price — All Valuation Models
Roselabs Finance fair value range ₹6–₹6 vs current market price ₹20.80 across 1 valuation models. For current market price and key ratios, visit ROSELABS share price.
ROSELABS Intrinsic Value Analysis — Undervalued or Overvalued?
Roselabs Finance median intrinsic value ₹6.24, current price ₹20.80 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of ROSELABS?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Roselabs Finance (ROSELABS) is ₹6.24 (median value). With the current market price of ₹20.80, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹6.24 to ₹6.24, indicating ₹6.24 - ₹6.24.
Is ROSELABS undervalued or overvalued?
Based on our multi-method analysis, Roselabs Finance (ROSELABS) appears to be trading above calculated value by approximately 70.0%.
ROSELABS Financial Health — Key Ratios vs Industry Benchmarks
Roselabs Finance financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -1.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
ROSELABS Cash Flow Quality — Operating & Free Cash Flow
Roselabs Finance operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |